secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2024-11-15T23:59:59+00:00
Accession:  0001104659-24-119756
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio receives Nasdaq delist notice but granted extension; interim CFO resigns, CEO takes over
--------------------------------------------------------------------------------

- Nasdaq Staff issued delist determination on Nov 13, 2024 for non-compliance with bid price rule.
- Nasdaq Hearings Panel granted extension to Jan 31, 2025 for bid price and Feb 18, 2025 for equity rule compliance.
- James Murphy resigned as Interim CFO on Nov 12, 2024; no disagreement involved.
- President/CEO Manuel Litchman appointed Interim CFO effective Nov 15, 2024; previously held role in Dec 2023-Jan 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465924119756/0001104659-24-119756-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465924119756/tm2428644d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-119756

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer